For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Published 2007-08-01 00:00:00
Perindopril arginine with indapamide (Coversyl Plus) was PBS listed on 1 May 2007. In late 2006, perindopril preparations (Coversyl) changed to a new formulation — from perindopril erbumine to perindopril arginine, with the erbumine salt being phased out during 2007 (see In Briefs, August 2006). Until recently the combination preparation perindopril with indapamide (Coversyl Plus) still contained the erbumine salt.
Although the strength differs with the new formulation, the two preparations are bioequivalent — that is, perindopril arginine 5 mg with indapamide 1.25 mg is bioequivalent to perindopril erbumine 4 mg with indapamide 1.25 mg. There is no difference in appearance between the two Coversyl Plus formulations.
Date published: 2007-08-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.